Drug Trial Radar · NCT03117894
PECS-2 for Breast Surgery
Last checked: Nov 20, 2026Latest source record: Jun 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Actual
Start
May 23, 2017
Primary completion
Oct 22, 2020
Study completion Oct 22, 2020
Sponsor
- Lead sponsor
- Umeå UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 18, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
There is no consensus regarding which alternative is the best anesthesia for breast surgery, general anesthesia and morphine for postoperative analgesia or a combination of regional anesthesia and general anesthesia that possibly attenuates or abolishes the need for morphine. The current study aims to determine which of the two strategies that is best in relation to postoperative pain, nausea and risk of recurrence of the disease.
Conditions
- Breast Neoplasm Female
- Regional Anesthesia
- Anesthesia
- Regional Anesthesia Morbidity
- Anesthesia Morbidity
Interventions
Ropivacaine 5 mg/ml, 35 mlDrug
Regional Anesthesia. The deposition of local anesthetics in proximity of nerves with the aim of blocking nerve transmission. This is used to block pain as an alternative to systemic treatment of pain.
Remifentanil 50 microg/mlDrug
The intravenous administration of anesthetics aiming to induce analgesia (part of the general anesthesia). No fixed dose, administered in relation to the study participants need at the moment.
Betamethason 4 mgDrug
Are meant to decrease the risk of so called postoperative nausea and vomiting (PONV). Administered preoperatively.
Paracetamol 1,5 gDrug
Administered preoperatively to prevent pain postoperatively.
PropofolDrug
The intravenous administration of anesthetics aiming to induce sleep (part of the general anesthesia). No fixed dose, administered in relation to the study participants need at the moment.
Arcoxia, 120 mgDrug
Administered preoperatively to prevent pain postoperatively.
Ondansetron 4 mgDrug
Are meant to decrease the risk of so called postoperative nausea and vomiting (PONV). Administered peroperative.
MorphineDrug
Administered peroperative, at the end of the surgery, before awakening the study participant. The aim is to prevent pain.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Opiate consumptionTime frame: 48 hours
- All cause mortalityTime frame: 3 years and 5 years.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Östersund Hospital
Östersund, Jämtland County, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.